Page last updated: 2024-11-07

spironolactone and Epistaxis

spironolactone has been researched along with Epistaxis in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Epistaxis: Bleeding from the nose.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CRANE, MG1
ANDES, JP1
HARRIS, JJ1
SLATE, WG1

Other Studies

1 other study available for spironolactone and Epistaxis

ArticleYear
PRIMARY ALDOSTERONISM IN PREGNANCY.
    Obstetrics and gynecology, 1964, Volume: 23

    Topics: Adolescent; Black People; Clinical Laboratory Techniques; Diagnosis, Differential; Epistaxis; Female

1964